Lucid Diagnostics Executes First Direct Employer Contract to Provide EsoGuard® Esophageal Precancer Testing as an Employee Benefit

EsoGuard Testing now incorporated in Texas-based Ancira Auto Group’s corporate Health and Wellness Program NEW YORK, Aug. 24, 2023 /PRNewswire/ — Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”) a commercial-stage, cancer prevention medical diagnostics company and…

Go to Source